Mirae Asset Global Etfs Holdings Ltd. Longboard Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 13,016 shares of LBPH stock, worth $375,771. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,016Holding current value
$375,771% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LBPH
# of Institutions
101Shares Held
34.1MCall Options Held
8.5KPut Options Held
31.1K-
Ra Capital Management, L.P. Boston, MA3.29MShares$95 Million1.34% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.94MShares$84.9 Million0.38% of portfolio
-
Cormorant Asset Management, LP Boston, MA2.79MShares$80.6 Million5.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$72.4 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$68.4 Million0.0% of portfolio
About Longboard Pharmaceuticals, Inc.
- Ticker LBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,586,000
- Market Cap $392M
- Description
- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...